{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "REGULAR", "exchange": "NMS", "shortName": "Gossamer Bio, Inc.", "longName": "Gossamer Bio, Inc.", "messageBoardId": "finmb_548541911", "exchangeTimezoneName": "America/New_York", "market": "us_market", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": -1.260513, "regularMarketPrice": 1.175, "firstTradeDateMilliseconds": 1549636200000, "regularMarketChange": -0.015000105, "regularMarketTime": 1684258639, "regularMarketDayHigh": 1.22, "regularMarketDayRange": "1.14 - 1.22", "regularMarketDayLow": 1.14, "regularMarketVolume": 714998, "regularMarketPreviousClose": 1.19, "bid": 1.17, "ask": 1.18, "bidSize": 40, "askSize": 22, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 1.17, "averageDailyVolume3Month": 3304836, "averageDailyVolume10Day": 1332610, "fiftyTwoWeekLowChange": 0.26499993, "fiftyTwoWeekLowChangePercent": 0.2912087, "fiftyTwoWeekRange": "0.91 - 15.195", "fiftyTwoWeekHighChange": -14.0199995, "fiftyTwoWeekHighChangePercent": -0.9226719, "fiftyTwoWeekLow": 0.91, "fiftyTwoWeekHigh": 15.195, "earningsTimestamp": 1683662460, "earningsTimestampStart": 1691409660, "earningsTimestampEnd": 1691755260, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.41, "epsForward": -1.49, "epsCurrentYear": -1.84, "priceEpsCurrentYear": -0.63858694, "sharesOutstanding": 95444096, "bookValue": 0.128, "fiftyDayAverage": 1.22542, "fiftyDayAverageChange": -0.050420046, "fiftyDayAverageChangePercent": -0.041145116, "twoHundredDayAverage": 6.371605, "twoHundredDayAverageChange": -5.1966047, "twoHundredDayAverageChangePercent": -0.81558806, "marketCap": 131772720, "priceHint": 4, "forwardPE": -0.78859055, "priceToBook": 9.179687, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Gossamer Bio", "symbol": "GOSS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3013 Science Park Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 684 1300", "website": "https://www.gossamerbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 178, "companyOfficers": [{"maxAge": 1, "name": "Mr. Faheem  Hasnain", "age": 64, "title": "Co-Founder, CEO, Pres & Chairman", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 902525, "fmt": "902.52k", "longFmt": "902,525"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bryan  Giraudo", "age": 47, "title": "COO & CFO", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 690593, "fmt": "690.59k", "longFmt": "690,593"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Richard  Aranda M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 625241, "fmt": "625.24k", "longFmt": "625,241"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christian  Waage", "age": 55, "title": "Exec. VP of Technical Operations & Admin.", "yearBorn": 1967, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Laura L. Carter Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeff  Boerneke", "title": "Gen. Counsel & Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Deanna  Weber", "title": "Sr. VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mario  Orlando", "title": "Sr. VP of Commercial New Product Planning", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Caryn L. Peterson", "age": 63, "title": "Exec. VP of Regulatory Affairs", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Matt  Cravets", "title": "Sr. VP of Biometrics", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}